In this regard, a detailed study by Cordaro et al. [22] demonstrated the PPAR-γ-dependent anti-inflammatory action exerted by Adelmidrol in a model of DNBS-induced colitis in mice, suggesting that the effect of such a molecule mostly depends on the activation of the above-mentioned receptor at the intestinal site. The gene discussed is PPARG; the disease is colitis.